Heidelberg University
Germany
His primary areas of study are Neuromyelitis optica, Pathology, Multiple sclerosis, Immunology and Myelitis. His Neuromyelitis optica study incorporates themes from Transverse myelitis, Aquaporin 4, Autoantibody and Optic neuritis. His work carried out in the field of Pathology brings together such families of science as Peripheral nervous system, Neuromyelitis Optica Spectrum Disorders, Subclass and Rituximab.
His Multiple sclerosis research incorporates themes from Differential diagnosis, Internal medicine, Pediatrics and Optic nerve. Sven Jarius interconnects Disease activity and Pleocytosis in the investigation of issues within Immunology. His research in Myelitis intersects with topics in Dysesthesia, Neurology and Cerebrospinal fluid.
Sven Jarius focuses on Neuromyelitis optica, Multiple sclerosis, Immunology, Pathology and Antibody. His Neuromyelitis optica study integrates concerns from other disciplines, such as Aquaporin 4, Internal medicine, Transverse myelitis, Myelitis and Optic neuritis. The concepts of his Multiple sclerosis study are interwoven with issues in Dermatology, Neurology, Flow cytometry and Optic nerve.
Many of his studies involve connections with topics such as Cerebrospinal fluid and Immunology. The Pathology study combines topics in areas such as White matter, Magnetic resonance imaging, Limbic encephalitis, Central nervous system and Neurological disorder. His study on Serology is often connected to Recombinant DNA as part of broader study in Antibody.
His main research concerns Multiple sclerosis, Optic neuritis, Neuromyelitis optica, Myelin oligodendrocyte glycoprotein and Internal medicine. His study with Multiple sclerosis involves better knowledge in Immunology. Sven Jarius has researched Optic neuritis in several fields, including Pediatrics and Optic nerve.
His research in Neuromyelitis optica is mostly focused on NMO Spectrum Disorders. His research integrates issues of Autoantibody, Controlled studies and Myelitis in his study of Myelin oligodendrocyte glycoprotein. His Internal medicine research is multidisciplinary, incorporating perspectives in Gastroenterology, Chronic pain, Depression and Rituximab.
Sven Jarius spends much of his time researching Multiple sclerosis, Neuromyelitis optica, Neurology, Myelin oligodendrocyte glycoprotein and Optic neuritis. His Multiple sclerosis research incorporates elements of Autoantibody, Retinal ganglion cell, Optic neuropathy and Pathology. His study in Transverse myelitis extends to Pathology with its themes.
His work investigates the relationship between Neuromyelitis optica and topics such as Cerebrospinal fluid that intersect with problems in Histopathology. Sven Jarius has included themes like Demyelinating disease, Internal medicine, Cohort study, CSF pleocytosis and Antibody in his Neurology study. His Myelin oligodendrocyte glycoprotein study which covers Myelitis that intersects with Acute disseminated encephalomyelitis and Pediatrics.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
International consensus diagnostic criteria for neuromyelitis optica spectrum disorders
Dean M. Wingerchuk;Brenda Banwell;Jeffrey L. Bennett;Philippe Cabre.
Neurology (2015)
MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome
Sven Jarius;Klemens Ruprecht;Ingo Kleiter;Nadja Borisow.
Journal of Neuroinflammation (2016)
Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients
Sven Jarius;Klemens Ruprecht;Brigitte Wildemann;Tania Kuempfel.
Journal of Neuroinflammation (2012)
Update on the diagnosis and treatment of neuromyelitis optica: recommendations of the Neuromyelitis Optica Study Group (NEMOS)
Corinna Trebst;Sven Jarius;Achim Berthele;Friedemann Paul;Friedemann Paul.
Journal of Neurology (2014)
AQP4 antibodies in neuromyelitis optica: diagnostic and pathogenetic relevance
Sven Jarius;Brigitte Wildemann.
Nature Reviews Neurology (2010)
Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders.
Simone Mader;Viktoria Gredler;Kathrin Schanda;Kevin Rostasy.
Journal of Neuroinflammation (2011)
MOG encephalomyelitis: International recommendations on diagnosis and antibody testing
S. Jarius;F. Paul;F. Paul;O. Aktas;N. Asgari.
Journal of Neuroinflammation (2018)
Antibody to aquaporin-4 in the Long-Term Course of Neuromyelitis Optica
S Jarius;F Aboul-Enein;P Waters;B Kuenz.
Brain (2008)
MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin.
Sven Jarius;Klemens Ruprecht;Ingo Kleiter;Nadja Borisow.
Journal of Neuroinflammation (2016)
Mechanisms of Disease: aquaporin-4 antibodies in neuromyelitis optica
Sven Jarius;Friedemann Paul;Diego Franciotta;Patrick Waters.
Nature Reviews Neurology (2008)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University Hospital Heidelberg
Max Delbrück Center for Molecular Medicine
Innsbruck Medical University
University of Oxford
TU Dresden
University of Oxford
University of Ulm
Mayo Clinic
Harvard Medical School
Heinrich Heine University Düsseldorf
Umeå University
Sejong University
Microsoft (United States)
MIT
Colorado School of Mines
Peking University
University of Groningen
University of Michigan–Ann Arbor
Stanford University
Université Côte d'Azur
United Arab Emirates University
Birkbeck, University of London
Hospital of the University of Pennsylvania
University of Michigan–Ann Arbor
University of California, Santa Barbara
National Aeronautics and Space Administration